Idioma:

Treatment of Hemophilia with Glycine-Precipitated Factor VIII

Abildgaard, Charles F ; Simone, Joseph V ; Corrigan, James J ; Seeler, Ruth A ; Edelstein, Gerald ; Vanderheiden, Jane ; Schulman, Irving

The New England journal of medicine, 1966-09, Vol.275 (9), p.471-475 [Periódico revisado por pares]

Sem texto completo

Citações Citado por

Título:
Treatment of Hemophilia with Glycine-Precipitated Factor VIII
Autor: Abildgaard, Charles F ; Simone, Joseph V ; Corrigan, James J ; Seeler, Ruth A ; Edelstein, Gerald ; Vanderheiden, Jane ; Schulman, Irving
É parte de: The New England journal of medicine, 1966-09, Vol.275 (9), p.471-475
Descrição: EFFECTIVE hemostasis can be achieved in most simple bleeding episodes of classic hemophilia by the use of fresh, fresh-frozen or lyophilized plasma as the source of antihemophilic factor (AHF, factor VIII). In the event of major trauma or surgical procedures sustained levels of 20 to 30 per cent of factor VIII are necessary to provide hemostasis. Such levels are often impossible to achieve with the use of plasma, and attempts to maintain hemostasis with repeated infusions may lead to congestive heart failure owing to the resulting overexpansion of total plasma volume. Recently, concentrated forms of factor VIII that provide safer . . .
Editor: Massachusetts Medical Society
Idioma: Inglês

Voltar para lista de resultados